Brief: Targovax Q3 Operating Loss Narrows To NOK 26.7 Million
Nov 7 (Reuters) - Targovax ASA TRVX.OL :
* Q3 TOTAL OPERATING REVENUE NOK 6,000 VERSUS NOK 6,000 YEAR
AGO
* Q3 OPERATING LOSS NOK 26.7 MILLION VERSUS LOSS NOK 33.7
MILLION
YEAR AGO
Source text for Eikon: ID:nWkrSrZ78
Further company coverage: TRVX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Circio Holding ASA
See all newsBrief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration
Brief: Circio And Aavigen To Collaborate On In Heart Gene Therapy
Brief: Circio Commences Exercise Period For Warrants
Brief: Circio Holding Files New Circvec Patent Application
Brief: Circio, Traffikgene Enter Research Collaboration